Effects of a Sedentary vs. Active Lifestyle on Blood Glucose Uptake

Please see the pdf version of the abstract

Adsorption Refrigeration Technologies

This chapter introduces a comprehensive overview about the principles, challenges and applications of adsorption refrigeration systems (ARSs), as a promising sustainable solution for many of cooling and heating applications. In addition to the features and the basics of ARSs, the following topics have been covered such as characteristics of working pairs, trends in improving the heat and mass transfer of the adsorber; advanced adsorption cycles and performance and operational data of some adsorption refrigeration applications. In some details, the operating range and the performance of ARSs are greatly affected by the employed working adsorbent/refrigerant pairs. Therefore, the study, development and optimum selection of adsorbent/refrigerant pairs, particularly the composite adsorbents, can lead to improving the performance and reliability of ARSs. Regarding the enhancement of heat and mass transfer in the adsorbent bed, two methods are commonly used: one is the development of adsorbents through different coating technologies or new materials such as metal-organic frameworks, and the second is the optimization of the adsorber geometrical parameters and cycle modes. Finally, a brief on some adsorption chillers applications have started to find their share in markets and driven by solar or waste heats

Gauge Dependence of Mass and Condensate in Chirally Asymmetric Phase of Quenched QED3

We study three dimensional quenched Quantum Electrodynamics in the bare vertex approximation. We investigate the gauge dependence of the dynamically generated Euclidean mass of the fermion and the chiral condensate for a wide range of values of the covariant gauge parameter $\xi$. We find that (i) away from $\xi=0$, gauge dependence of the said quantities is considerably reduced without resorting to sophisticated vertex {\em ansatze}, (ii) wavefunction renormalization plays an important role in restoring gauge invariance and (iii) the Ward-Green-Takahashi identity seems to increase the gauge dependence when used in conjunction with some simplifying assumptions. In the Landau gauge, we also verify that our results are in agreement with those based upon dimensional regularization scheme within the numerical accuracy available.Comment: 14 pages, 11 figures, uses revte

Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper

Routine childhood vaccinations are key for the protection of children from a variety of serious and potentially fatal diseases. Current pediatric vaccine schedules mainly cover active vaccines. Active vaccination in infants is a highly effective approach against several infectious diseases; however, thus far, for some important viral pathogens, including respiratory syncytial virus (RSV), vaccine development and license by healthcare authorities have not been accomplished. Nirsevimab is a human-derived, highly potent monoclonal antibody (mAb) with an extended half-life for RSV prophylaxis in all infants. In this manuscript, we consider the potential implications for the introduction of an anti-viral mAb, such as nirsevimab, into the routine pediatric vaccine schedule, as well as considerations for coadministration. Specifically, we present evidence on the general mechanism of action of anti-viral mAbs and experience with palivizumab, the only approved mAb for the prevention of RSV infection in preterm infants, infants with chronic lung disease of prematurity and certain infants with hemodynamically significant heart disease. Palivizumab has been used for over two decades in infants who also receive routine vaccinations without any alerts concerning the safety and efficacy of coadministration. Immunization guidelines (Advisory Committee on Immunization Practices, Joint Committee on Vaccination and Immunization, National Advisory Committee on Immunization, Centers for Disease Control and Prevention, American Academy of Pediatrics, The Association of the Scientific Medical Societies in Germany) support coadministration of palivizumab with routine pediatric vaccines, noting that immunobiologics, such as palivizumab, do not interfere with the immune response to licensed live or inactivated active vaccines. Based on the mechanism of action of the new generation of anti-viral mAbs, such as nirsevimab, which is highly specific targeting viral antigenic sites, it is unlikely that it could interfere with the immune response to other vaccines. Taken together, we anticipate that nirsevimab could be concomitantly administered to infants with routine pediatric vaccines during the same clinic visit